RecruitingPhase IIEN originalBladder cancer

Bladder Preservation for Patients With Muscle Invasive Bladder Cancer (MIBC) With Variant Histology

⚠️

This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.

About the trial

This is a Phase II, single cohort study designed to evaluate outcomes in patients with muscle invasive bladder cancer (MIBC) with variant histology who receive neoadjuvant chemotherapy (NAC) with or without immunotherapy (IO) followed by trimodal therapy (TMT). Enrolled patients will undergo at least 3 cycles of NAC +/- IO (oncologist's choice) followed by a four- or six-week course of concurrent standard of care chemotherapy and radiation therapy. These patients will be compared with historical controls of patients with a diagnosis of pure urothelial carcinoma who have undergone TMT. This study has been designed to test the hypothesis that variant histology TMT can be delivered within 45 days of NAC +/- IO and is therefore a viable option in patients who are risk of systemic disease spread.

Original English text from ClinicalTrials.gov

Who can (and can't) join

✓ Qualifies

  • Potwierdzony diagnoza raka pęcherza moczowego z nienormalnymi komórkami nowotworowymi
  • Guz znajduje się w mięśniu pęcherza (stopień zaawansowania cT2-T4N0M0)
  • Przeprowadzona procedura pobrania próbki z pęcherza (TURBT) i badania obrazowe (CT, PET)
  • Napisana zgoda na uczestnictwo w badaniu

✗ Disqualifies

  • Obecność rozsianych zmian nowotworowych w pęcherzu (diffuse cis)
  • Obustronny zator moczowodu spowodowany opuchlizną
  • Wcześniejsza radioterapia miednicy
  • Poprzednie leczenie chemioterapią tego nowotworu
  • Obecny lub niedawny (w ciągu ostatnich 5 lat) inny nowotwór

Simplified criteria — AI translation

Trial details

Minimum age
18 Years
Last updated (source)
August 6, 2026
Sex
No restrictions

Therapies / drugs in trial

Locations (1)

Cedars Sinai Medical Center

Los Angeles, United States

Trial contact

Contact information from ClinicalTrials.gov. Contact in English.

Share this trial

Data from ClinicalTrials.gov. AI-assisted translation, last sync: 8/7/2026.

You can help another person

We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.